Category: neuroendocrine cancer
9 Conferences for the Carcinoid and Neuroendocrine Tumor Community
If you are a carcinoid or NET cancer survivor, caregiver, family member or medical professional you can learn about what’s happening now and what’s new in carcinoid/NETs treatments, clinical trials, research, and more from specialists…
READ MOREMusic for the Carcinoid and Neuroendocrine Tumor Community
What music has been important to you on your journey as a carcinoid neuroendocrine tumor survivor? We asked this question on the Carcinoid Cancer Foundation’s Facebook page and got a wonderful variety of responses that we are sharing here with videos …
READ MORECarcinoid Cancer Foundation’s May 2011 Symposium Now Online
The Carcinoid Cancer Foundation is pleased to share with you videos from its carcinoid/NET symposium, “Neuroendocrine Tumor Management: The Era of Personalized Medicine,” held on May 1, 2011 at Mt. Sinai Medical Center in New York City.
Following …
READ MOREWorldwide NET Cancer Awareness Day Updates
With less than five months until the second Worldwide NET Cancer Awareness Day on Thursday, November 10, 2011, there have been many exciting developments to share with the carcinoid and NET community.
The first Chinese NET website (www.net.org.tw) …
READ MOREUp-to-the-Minute: News for the Carcinoid and Neuroendocrine Tumor Community
The first device that simultaneously performs PET and MRI scans, a new alpha-emitter-based therapy for NET cancer patients with progressive therapy-resistant tumors, the first–ever randomized virtual clinical trial, over 100 abstracts on carcinoid…
READ MORE6 iPhone, Droid, BlackBerry, and iPad Apps for Carcinoid Patients and Physicians
A new iPhone app from ASCO, an app from 3M for physicians to help them manage and keep track of patient data, and the American Cancer Society’s Journals app are some of the newest mobile apps in the areas of medicine and healthcare. For carcinoid and neuroendocrine…
READ MORE1st World Congress on Gallium-68 and Peptide Receptor Radionuclide Therapy (PRRNT)
Since 1997, when he first used the radiolabeled peptide Y-90 DOTATOC (a somatostatin analogue) to treat a 15-year-old boy with a rare neuroendocrine tumor, called paraganglioma, and saw the boy go from being wheelchair-bound and in terrible pain to …
READ MORECNETS Canada Presents 2011 Halifax Neuroendocrine Conference for Patients and Medical Professionals
Carcinoid and neuroendocrine tumor patients and medical professionals are invited to attend the 2011 Halifax Conference, presented by the Canadian Neuroendocrine Tumour Society (CNETS). The conference will be held on Saturday, May 7 at the beautiful…
READ MORECarcinoid Cancer Foundation to Speak on Behalf of NET Cancer Patients at April 12, 2011 FDA Oncologic Drugs Advisory Committee Meeting
Grace Goldstein, Chief Operating Officer of the Carcinoid Cancer Foundation, will speak at the Open Public Hearing segment during the U.S. Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee Meeting on April 12, 2011 in Silver …
READ MORERadioMedix $2.8 Million Grant from Texas Emerging Technology Fund to Result in New Products that Benefit Carcinoid and Neuroendocrine Cancer Patients
Two innovative products that will enable users to generate and label PET radiotracers on-site at a significantly reduced cost will be developed by RadioMedix, Inc. with a $2.8 million grant from the Texas Emerging Technology Fund. According to Ebrahim…
READ MORE